This is from Peter Attiaâs newsletter this morning, discussing the potential benefit of creatine in treating depression. No issues with this whatsoever. The problem I have is that when they say âCBT,â which I practice, what do they mean? This is the worldâs largest umbrella, essentially the impact of thoughts, feelings, and behavior on one another. So Iâm all about positive psychology and self-esteem, and if I had a motto it would probably be Eleanor Rooseveltâs âNo one can be made to feel inferior without their consent,â with âinferiorâ easily subbed out with words like âresponsible,â âguilty,â âugly,â âslutty,â or what have you.
Other therapists practicing CBT have worksheets offering the standard cognitive distortions, and so the therapy consists in identifying which youâre doing and making strategies not to, or whatever. Very curriculum-driven.
Not all therapists are intelligent, insightful, learned, sensitive, etc. Many are burnt out.
Theyâre always careful to match apples to apples in terms of the study participants, but what about the therapists in these studies of therapy? Every time I read a study of this sort, this piece bangs at me. Anyone have any insight?
Also, the article is interesting nonetheless. An excerpt:
An emerging role for creatine with behavioral therapy
For this double-blind, randomized controlled trial, authors Sherpa et al. examined 100 participants in India with clinical diagnoses of depression. Participants (mean age 30.4 ±7.4 years, 50% female) were randomized to either CBT plus creatine (5 g/day) or CBT plus placebo for a treatment period of 8 weeks.8 The CBT protocol for both groups involved a total of five 45-min CBT sessions (one every other week), and the primary outcome â improvement in symptom severity â was assessed by the Patient Health Questionnaire-9 (PHQ-9), a standard method for evaluating depressive symptoms. Scores on the PHQ-9 can range from 0 to 27, with higher scores indicating more severe depression (mild depression: scores of 5â9, moderate: 10â14, moderate-severe: 15â19, and severe: â„20).
Results indicated that both groups improved significantly in symptom severity from baseline to the 8-week timepoint. However, the creatine group showed statistically significantly greater improvements, with scores dropping an additional 5.12 points compared to placebo (95% CI: â7.20 to â3.52). Specifically, the CBT-creatine group moved from moderately severe depression (17.8±6.1) to mild depression (5.8±4.8), while the CBT-placebo group remained in the moderate range (shifting from 17.6±6.4 to 11.9±6.6). Additionally, twelve participants in the CBT-creatine group achieved remission (PHQ-9 score <5) compared with five in the CBT-placebo group.
While these findings represent the intention-to-treat cohort (i.e., all participants who started treatment, regardless if they completed the entire treatment protocol), dropout rates were high among both groups (around 40%). This certainly may have impacted results, as those who dropped out may have been experiencing less benefit from either treatment. Indeed, the authors also conducted per-protocol analyses (i.e., excluding drop-outs) and reported a slightly greater difference between groups (the mean improvement in the CBT-creatine group exceeded that of the CBT-placebo group by 6.07 points, 95% CI: â7.88 to â4.25).
However, an important limitation of this study is that it lacked any comparison to traditional pharmacological antidepressants, and thus, we are restricted in our ability to fully understand the scale of this effect. A difference of five points on the PHQ-9 scale is unequivocally clinically significant, so these new data from Sherpa et al. suggest that creatine can indeed improve outcomes from CBT compared to placebo (though itâs worth noting that the CBT protocol employed here was very light compared to more typical weekly or twice-weekly sessions). Further, according to a meta-analysis including over 50,000 patients, CBT is often just as effective as pharmacological therapies, and individuals who combine medications with CBT fare better than with either treatment alone,9 but is the combination of creatine and CBT as effective as a combination of SSRIs and CBT? If so, this opens new avenues for patients who do not respond to SSRIs or do not tolerate their side effects to achieve comparable relief as others achieve on traditional medications. Perhaps creatine added to both CBT and antidepressants would show still greater benefit, offering hope to those with the most severe forms of depression. We currently have no direct comparisons to answer these questions, so further clinical studies are warranted.
An emerging role for creatine supplementation in the treatment of depression - Peter Attia


